After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Abbott Laboratories is $235.56B. A total of 6.39 million shares were traded on the day, compared to an average of 5.79M shares.
In the most recent transaction, Ford Robert B sold 285,388 shares of ABT for 131.17 per share on Feb 05 ’25. After the transaction, the CHAIRMAN AND CEO now owns 220,059 company shares. In a previous transaction on Feb 05 ’25, Robert B. Ford bought 285,388 shares at 131.17 per share.
Among the insiders who sold shares, ALLEN HUBERT L disposed of 131,360 shares on Jan 29 ’25 at a per-share price of $128.35. This resulted in the EXECUTIVE VICE PRESIDENT holding 184,806 shares of ABT after the transaction. In another insider transaction, ALLEN HUBERT L sold 58,428 shares at $128.07 per share on Jan 30 ’25. Company shares held by the EXECUTIVE VICE PRESIDENT now total 184,806.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. Abbott Laboratories pays an annual dividend of $2.24, resulting in a dividend yield of 1.65%, and it has a price to earnings (P/E) ratio of 17.73. ABT’s most recent ex-dividend date was 1.75% when it declared a $0.59 quarterly dividend that was paid in cash on 4/15/2025. Previously, the company paid the dividend on 1/15/2025 with an ex-dividend date of 2.08%. The ABT stock dividend was $0.59 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, ABT has a high of $136.59 and a low of $99.71.
As of this writing, ABT has an earnings estimate of $1.06 per share for the current quarter. EPS was calculated based on a consensus of 20.0 estimates, with a high estimate of $1.08 per share and a lower estimate of $0.98.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ABT’s latest balance sheet shows that the firm has $10.25B in Cash & Short Term Investments as of fiscal 2021. There were $19.01B in debt and $13.11B in liabilities at the time. Its Book Value Per Share was $27.52, while its Total Shareholder’s Equity was $36.02B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ABT is Buy with a score of 4.44.
